Loading clinical trials...
Loading clinical trials...
Everolimus is an immunosuppressive drug that is being studied for preventing acute rejection that can happen after heart transplantation. It is usually used in combination with other immunosuppressiv...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis Pharmaceuticals
NCT00106925 · Graft-versus-leukemia, Graft vs Host Disease, and more
NCT06532890 · Cardiac Failure, Graft Rejection
NCT05333367 · Cutaneous T-Cell Lymphoma, Graft Vs Host Disease, and more
NCT07316829 · Graft Rejection, Kidney Transplantation, and more
NCT03719339 · Renal Transplant Rejection, Pediatric Kidney Disease, and more
UCLA Medical Center
Los Angeles, California
University of Minnesota, Fairfield University Hospital
Minneapolis, Minnesota
Columbia Presbyterian Medical Center
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions